These results highlight the potential importance of YAP activation in mediating resistance to MAPK pathway inhibition and suggest YAP inhibition as a potential strategy to enhance the efficacy of MAPK pathway inhibition in patients with HNSCC [118]. Here, YAP1 is linked to head and neck squamous cell carcinoma.